Trial · NCT07301034
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in percent atheroma volume (PAV) as determined by greyscale intravascular ultrasound (IVUS) in matched regions of interest | From randomisation (week 0) to end-of-study (52-week) | Percentage (%). |
| Secondary | Change in maximum lipid core burden index (LCBI) in any 4-mm segment(maxLCBI4mm) as determined by Near-infrared spectroscopy (NIRS) in matched regions of interest | From randomisation (week 0) to end-of-study (52-week) | Lipid core burden index (LCBI) (0 to 1000). |
| Secondary | Change in minimal fibrous cap thickness as determined by (optical coherence tomography) OCT in matched regions of interest | From randomisation (week 0) to end-of-study (52-week) | Micro meter (µmeter). |
| Secondary | Change in lipid core burden index (LCBI) total as determined by NIRS in matched regions of interest | From randomisation (week 0) to end-of-study (52-week) | LCBI index (0 to 1000). |
| Secondary | Change in average angular extension (AAE) of macrophages as determined by OCT in matched regions of interest | From randomisation (week 0) to end-of-study (52-week) | Degrees (°). |
| Secondary | Change in normalized total atheroma volume (NTAV) by IVUS in matched regions of interest | From randomisation (week 0) to end-of-study (52-week) | Cubic Millimeter (mm3). |
| Secondary | Change in mean fibrous cap thickness as determined by OCT in matched region of interest | From randomisation (week 0) to end-of-study (52-week) | µmeter. |
| Secondary | Change in interleukin6 (IL-6) | From randomisation (week 0) to week 4, and week 52 | Picograms per milliliter (pg/mL). |
| Secondary | Change in high-sensitivity C-reactive protein (hs-CRP) | From randomisation (week 0) to week 4, and week 52 | Milligrams per deciliter (mg/dL). |
| Secondary | Change in high-sensitivity Troponin T (hs-TnT) | From randomisation (week 0) to week 4, and week 52 | Nanograms per milliliter (ng/mL). |
| Secondary | Change in N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) | From randomisation (week 0) to week 4, and week 52 | Picograms per milliliter (pg/mL). |
| Secondary | Change in lipid and inflammatory markers | From randomisation (week 0) to week 4, and week 52 | |
| Secondary | Time to first occurrence of: All-cause death | From randomisation (week 0) to end-of-study (52 weeks) | Number of first occurrences and time-to-event. |
| Secondary | Time to first occurrence of: Cardiac death | From randomisation (week 0) to end-of-study (52-week) | Number of first occurrences and time-to-event. |
| Secondary | Time to first occurrence of:Non-fatal spontaneous myocardial infarction | From randomisation (week 0) to end-of-study (52-week) | Number of first occurrences and time-to-event. |
| Secondary | Time to first occurrence of: Any coronary revascularization | From randomisation (week 0) to end-of-study (52-week) | Number of first occurrences and time-to-event. |
| Secondary | Time to first occurrence of: Non-fatal stroke | From randomisation (week 0) to end-of-study (52-week) | Number of first occurrences and time-to-event. |
| Secondary | Time to first occurrence of:Transient ischemic attack | From randomisation (week 0) to end-of-study (52-week) | Number of first occurrences and time-to-event. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07301034/registered